# Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextrose (Dianeal 2.5%) in HOMA IR

> **NCT01093547** · PHASE4 · WITHDRAWN · sponsor: **Vantive Health LLC**

## Conditions studied

- End Stage Renal Disease
- Continuous Ambulatory Peritoneal Dialysis

## Interventions

- **PROCEDURE:** Blood samples
- **PROCEDURE:** Measure of peritoneal ultrafiltrates

## Key facts

- **NCT ID:** NCT01093547
- **Lead sponsor:** Vantive Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-02
- **Primary completion:** 2011-07
- **Final completion:** 2011-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01093547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01093547, "Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextrose (Dianeal 2.5%) in HOMA IR". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01093547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*